Canada is at the center of the cannabis universe right now. Most obviously, the country is edging closer and closer to getting a legal recreational program up and running. At the same time, there’s a frenzy of business activity. This means that now could be a good chance to invest. Here are 11 Canadian cannabis stocks to take a look at.
Liberty Health Sciences, Inc. (CNSX:LHS)
With a market cap just under $300 million and a lot of promising activity, Liberty Health is a strong stock to look at. The company is focused on the medical marijuana space. In particular, it’s an expert company when it comes to large-scale cultivation.
It has a bunch of deals in both Canada and the U.S. Most notably, Liberty has a strong relationship with Aphria, one of the best performing Canadian cannabis stocks.
MPX Bioceutical Corp. (CNSX:MPX)
MPX is another Canadian company with profitable projects in both the U.S and Canada. In particular, it owns a number of dispensaries across four states in the U.S.
As for its Canadian holdings, MPX is reportedly in the process of building a massive new production facility. All told, the company has a market cap above $360 million and has been a consistent performer.
Hydropothecary Corporation (TSX:HEXO)
Hydropothecary Corporation is making some potentially big moves. Its main source of activity comes as the only licensed medical cannabis producer in the province of Quebec.
Additionally, the company is apparently getting ready to launch a new brand called HEXO. This one will focus on recreational marijuana, just in time for legalization in Canada. The stock has seen increases above 200 percent over the last 12 months or so.
MedMen Enterprises (CSE:MMEN)
MedMen is technically based in the U.S. and they started out as a weed retailer based in California with stores throughout weed-legal states.
But in May, MedMen completed a “reverse takeover” of Ladera Ventures Corp. After that move, the company began trading on the Canadian Securities Exchange. When MedMen became one of the first Canadian cannabis stocks, it had a valuation well above $1 billion.
CannTrust Holdings, Inc. (TSX:TRST)
There are a couple reasons we consider CannTrust a solid investing option. First, the company has a deal with Appotex, Inc., a large pharmaceutical company in Canada.
For another, CannTrust has a grow facility in Ontario that produces consistently. And the company has some early stage plans to build a second cultivation site. Good growth could be on the horizon for CannTrust.
The Supreme Cannabis Company, Inc. (TSX:FIRE)
Right not could be an interesting time to invest in the Supreme Cannabis Company, although it could be one of the riskier stocks on this list. Supreme launched a private placement deal last year to raise funds for a new growing facility.
Reports showed that the stock made small gains in 2017 but has seen small declines throughout 2018. The slightly lower prices right now could make this an interesting stock to consider.
Cronos Group (TSX:CRON)
Cronos is all over Canada’s legal cannabis industry. It’s already involved in the process of producing medical marijuana, and it regularly seeks new opportunities to invest throughout the marijuana space.
As a result, the company now has a market cap just north of $1 billion. Expect solid and consistent performance from Cronos.
MedReleaf Corp. (TSX:LEAF)
MedReleaf is one of Canada’s most successful marijuana companies. It started out primarily in the medical marijuana space, producing high-grade medical products.
MedReleaf also has a number of lucrative agreements. It is a licensed supplier for the province of Quebec. It also has a deal to supply medical marijuana to Germany. More recently, the company was acquired by cannabis giant Aurora Cannabis.
Aphria, Inc. (TSX:APH)
With a market cap above $2.5 billion, Aphria is one of Canada’s biggest and most successful Canadian cannabis stocks. In fact, the stock has reportedly seen increases of 146 percent over the last year.
The company produces a wide range of cannabis flower and other marijuana products. These products are sold throughout the Canadian market. But the company has also expressed interest in expanding globally. In particular, Aphria was one of a handful of companies to express interest in getting into Greece’s recently-expanded medical marijuana market.
Aurora Cannabis, Inc. (TSX:ACB)
Aurora Cannabis, Inc. is one of the biggest Canadian cannabis stocks. It is currently valued at over $5 billion. Aurora has had a couple of big developments recently. In May, the company purchased MedReleaf, another wildly successful Canadian cannabis company.
Similarly, the company recently won a contract to supply medical marijuana to the Italian government. It will complete that arrangement by way of its Germany-based subsidiary Pedanios.
Canopy Growth (TSX:WEED)
Canopy Growth has been in more headlines recently than probably any other cannabis company in the world. In fact, the company has a long history of groundbreaking achievements. For starters, it was the first publicly traded cannabis company in North America.
Then, just a couple weeks ago, it made another pioneering move. More specifically, Canopy Growth became the first weed company to ever trade on the New York Stock Exchange. Since then, its stocks have been skyrocketing. Apparently, a lot of younger Millenial investors are snatching up Canopy Growth shares. The company reportedly has a market cap above $6 billion.
Canadian Cannabis Stocks
As you can see, there are all sorts of options for investing in Canadian marijuana stocks. It could be a great time to get into the game. With full legalization on the immediate horizon, it seems likely that there will be a whole lot more activity in the legal weed scene for the foreseeable future.